Kendall Capital Management Increases Holdings in United Therapeutics Co. (NASDAQ:UTHR) : vimarsana.com

Kendall Capital Management grew its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 45.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,212 shares of the biotechnology company’s stock after acquiring an additional 1,310 shares during the period. Kendall […]

Related Keywords

Wellington , New Zealand General , New Zealand , Blackrock , United States , Paula Mahon , Christopher Patusky , Leerink Partnrs , United Therapeutics Corporation , Wellington Management Group , Blackrock Inc , Norges Bank , Krensavage Asset Management , Goldman Sachs Group , Wells Fargo Company , United Therapeutics Co , Nasdaq , Securities Exchange Commission , Kendall Capital Management , United Therapeutics , Free Report , Capital Management , Management Group , Street Corp , Get Free Report , Director Christopher Patusky , Therapeutics Corporation , United Therapeutics Daily , Nasdaq Uthr , Uthr , Medical , 91307c10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,